Alnylam Pharmaceuticals, Inc.

Universal- Beteiligungs- und Servicegesellschaft mbH ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/28/2026

Shares

124,645

Value ($000)

49,397

Weight

0.1%

2024 Q4 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/28/2026	49,397	0.1%	124,645	12/31/2025
2025 Q3	10/30/2025	50,412	0.1%	110,552	9/30/2025
2025 Q2	8/11/2025	37,294	0.1%	114,366	6/30/2025
2025 Q1	5/6/2025	31,787	0.1%	117,720	3/31/2025
2024 Q4	2/28/2025	29,263	0.1%	124,360	12/31/2024